Paper Details

  1. Home
  2. Paper Details

Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.

Author: BrigoFrancesco, Del GiovaneCinzia, LattanziSimona, SilvestriniMauro, StrianoPasquale, TrinkaEugen, ZaccaraGaetano

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Cenobamate is a novel antiseizure medication with a dual mechanism of action. It enhances the inactive state of voltage-gated sodium channels and acts as a positive allosteric modulator of GABA<sub>A</sub> receptors.
Paper Details　
Original Abstract of the Article :
Label="BACKGROUND">Cenobamate is a novel tetrazole-derived carbamate compound with a dual mechanism of action. This drug can enhance the inactivated state of voltage-gated sodium channels, preferentially inhibiting the persistent component of the sodium channel current, and acts as a positive allost...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658084/

データ提供：米国国立医学図書館（NLM）

Cenobamate: A New Approach for Focal-Onset Seizures

This systematic review and meta-analysis delves into the world of epilepsy, focusing on the efficacy and safety of cenobamate, a novel anti-seizure medication, for treating focal-onset seizures in adults. Cenobamate operates through a dual mechanism of action, acting on both voltage-gated sodium channels and GABAA receptors, offering a potential advantage over existing anti-seizure medications.

A Promising Anti-Seizure Medication

The review analyzes the available evidence and concludes that cenobamate shows promising results in the treatment of focal-onset seizures. Cenobamate has been shown to effectively reduce seizure frequency and improve quality of life in patients with focal-onset seizures.

Expanding Treatment Options for Epilepsy

This review expands our understanding of treatment options for epilepsy, highlighting the potential benefits of cenobamate. As research continues to explore new and innovative approaches to managing seizures, this review provides valuable insights for healthcare professionals seeking to provide optimal care for patients with epilepsy.

Dr.Camel's Conclusion

Imagine the challenges of epilepsy as a relentless sandstorm, disrupting the life of an individual. Cenobamate, a new anti-seizure medication, offers a potential oasis, providing relief and stability in the face of this condition. This review sheds light on the promising potential of cenobamate for managing focal-onset seizures, offering hope for a more peaceful and fulfilling life for individuals living with epilepsy.
Date :
  1. Date Completed 2021-10-20
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

32851590

DOI: Digital Object Identifier

PMC7658084

Related Literature

Article Analysis
・Effects of cenobamate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.